Paper
RSC Advances
(aqueous citric acid) and evaporated to obtain yellow oil (1.45 g). 11 A. K. Pandey, D. Naduthambi, K. M. Thomas and
This crude product was puried by silica gel column chroma- N. J. Zondlo, J. Am. Chem. Soc., 2013, 135, 4333–4363.
tography (hexane–50% EtOAc, v/v) to obtain 12 (ref. 10) (1.07 g, 12 D. Papaioannou, G. Stavropoulos, K. Karagiannis,
5.03 mmol, 43%) and trans-13 (866 mg, 3.74 mmol, 32%). The
1H NMR spectra of these compounds were similar to the data of
their enantiomers, 10 and Boc-Hyp, respectively.
G. W. Francis, T. Brekke and D. W. Aksnes, Acta Chem.
Scand., 1990, 44, 243–251.
´
13 J. A. Gomez-Vidal and R. B. Silverman, Org. Lett., 2001, 3,
2481–2484.
14 N. K. Yee, V. Farina, I. N. Houpis, N. Haddad, R. P. Frutos,
F. Gallou, X.-j. Wang, X. Wei, R. D. Simpson, X. Feng,
V. Fuchs, Y. Xu, J. Tan, L. Zhang, J. Xu, L. L. Smith-
Keenan, J. Vitous, M. D. Ridges, E. M. Spinelli,
M. Johnson, K. Donsbach, T. Nicola, M. Brenner,
E. Winter, P. Kreye and W. Samstag, J. Org. Chem., 2006,
71, 7133–7145.
15 J. A. Smith, G. P. Savage and O. E. Hutt, Aust. J. Chem., 2011,
64, 1509–1514.
16 M. Seki and K. Matsumoto, Biosci., Biotechnol., Biochem.,
1995, 59, 1161–1162.
17 P. D. Croce and C. La Rosa, Tetrahedron: Asymmetry, 2002, 13,
197–201.
18 E.-S. H. El-Ashry and A. El Nemr, Carbohydr. Res., 2003, 338,
2265–2290.
19 H. B. Mereyala, G. Pathuri and L. Nagarapu, Synth. Commun.,
2012, 42, 1278–1287.
20 R. Hara and K. Kino, Biochem. Biophys. Res. Commun., 2009,
379, 882–886.
4-Benzyl derivatives of (2S)-hydroxyprolines, (2S,4S)-N-Boc-4-
benzyloxyproline (14)
The EtOH (3.0 mL) solution of 10 (213 mg, 1.00 mmol) was mixed
with 1.2 mL aqueous NaOH (1.0 mol Lꢂ1) for 1 h, then the mixture
was evaporated in vacuo. The residue was dissolved in 3.0 mL
THF, 55% NaH (52.4 mg, 1.2 mmol) and benzyl bromide (205 mg,
1.2 mmol) was added and stirred for 4 h. Aer evaporation, the
residue taken up in EtOAc was washed and again evaporated to
yield 14 as a white solid (267 mg, 83.1 mmol, 83%). 1H NMR
(CD3OD, 500 MHz, Fig. S10†): d 7.31 (m, 5H, Ph), 4.49 (m, 2H,
CH2Ph), 4.34 and 4.28 (m, total 1H, CaH), 4.16 (m. 1H, CgH), 3.61
(m, 1H, CgH), 3.48 (m, 1H, CgH), 2.34 (m, 2H, CbH), 1.46 and 1.43
(s, total 9H, Boc). 13C NMR (CD3OD, 125 MHz, Fig. S11†): d 175.9
and 175.6, 156.3 and 156.1, 139.5, 129.3, 129.0, 128.7, 81.5, 78.4
and 77.4, 73.2 and 72.0, 59.2 and 58.8, 53.4 and 52.7, 36.8 and
36.0, 28.6. ESI-MS: m/z 344 ([M + Na]+), 288 ([M + Na–C4H8]+), 244
([M + Na–C4H8–CO2]+); HR-ESI-MS [C17H23N1Na1O5]+ ([M + Na]+):
calculated ¼ 344.1474, found ¼ 344.1460.
¨
21 C. Klein and W. Huttel, Adv. Synth. Catal., 2011, 353, 1375–
1383.
Acknowledgements
22 K. Nakanishi, M. I. Nurul, L. A. Watanabe and N. Nishino, in
Peptide Science 2010, ed. N. Fujii and Y. Kiso, The Japanese
Peptide Society, 2011, p. 197.
23 B. S. Schricker, K. Thirring and H. Berner, Bioorg. Med. Chem.
Lett., 1992, 2, 387–390.
1H NMR NOESY spectra and ESI mass spectra were measured at
Institute for Materials Chemistry and Engineering, Kyushu
University.
ˇ
24 B. Mohar, A. Stimac and J. Kobe, Tetrahedron: Asymmetry,
Notes and references
1994, 5, 863–878.
1 M. Pekkala, R. Hieta, U. Bergmann, K. I. Kivirikko, 25 A. G. Myers and J. L. Gleason, Org. Synth., 1999, 76, 57–66.
`
R. K. Wierenga and J. Myllyharju, J. Biol. Chem., 2004, 279, 26 L. Saniere, L. Leman, J.-J. Bourguignon, P. Dauben and
52255–52261.
R. H. Dodd, Tetrahedron, 2004, 60, 5889–5897.
27 H. K. Chenault, J. Dahmer and G. M. Whitesides, J. Am.
Chem. Soc., 1989, 111, 6354–6364.
28 N. Nishino, T. Arai, Y. Ueno and M. Ohba, Chem. Pharm.
Bull., 1996, 44, 212–214.
29 L. A. Watanabe, S. Haranaka, B. Jose, M. Yoshida, T. Kato,
M. Moriguchi, K. Soda and N. Nishino, Tetrahedron:
Asymmetry, 2005, 16, 903–908.
2 J. Myllyharju, Top. Curr. Chem., 2005, 247, 115–147.
3 K. L. Gorres and R. T. Raines, Crit. Rev. Biochem. Mol. Biol.,
2010, 45, 106–124.
4 N. R. Rose, M. A. McDonough, O. N. F. King, A. Kawamura
and C. J. Schoeld, Chem. Soc. Rev., 2011, 40, 4364–4397.
5 R. A. Cacho, W. Jiang, Y.-H. Chooi, C. T. Walsh and Y. Tang,
J. Am. Chem. Soc., 2012, 134, 16781–16790.
6 A. M. Mandal, J. Hines, K. Kuramochi and C. M. Crews, 30 B. Layek and J. Singh, Biomacromolecules, 2013, 14, 485–494.
Bioorg. Med. Chem. Lett., 2005, 15, 4043–4047.
7 P. M. Simon, J. Pachence, B. Belinka, G. J. Poiani, S.-E. Lu,
31 K. J. Shaw, J. R. Luly and H. Rapoport, J. Org. Chem., 1985, 50,
4515–4523.
`
C. A. Tozzi and D. J. Riley, Pulm. Pharmacol. Ther., 2006, 19, 32 S. Hoarau, J. L. Fauchere, L. Pappalardo, M. L. Roumestant
242–250.
and P. Viallefont, Tetrahedron: Asymmetry, 1996, 7, 2585–
2593.
33 P. Allevi, M. Galligani and M. Anastasia, Tetrahedron:
Asymmetry, 2002, 13, 1901–1910.
34 N. Kurokawa and Y. Ohfune, J. Am. Chem. Soc., 1986, 108,
6041–6043.
8 B. T. M. Hoa, T. Hibi, R. Nasuno, G. Matsuo, Y. Sasano and
H. Takagi, J. Biosci. Bioeng., 2012, 114, 160–165.
9 M. D. Shoulders, F. W. Kotch, A. Choudhary, I. A. Guzei and
R. T. Raines, J. Am. Chem. Soc., 2010, 132, 10857–10865.
10 D. J. Pippel, L. K. Young, M. A. Letavic, K. S. Ly, B. Naderi,
A. Soyode-Johnson, E. M. Stocking, N. I. Carruthers and 35 D. Guillerm, K. Lavrador and G. Guillerm, Synth. Commun.,
N. S. Mani, J. Org. Chem., 2010, 75, 4463–4471.
1995, 25, 877–882.
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 2482–2490 | 2489